{"title":"孤儿核受体NR4A1同时调节人类间充质干细胞的成骨细胞生成和脂肪生成。","authors":"Yilan Jin, Youngho Son, Insun Song, Yoon-Sok Chung, Yong Jun Choi","doi":"10.3892/mmr.2024.13368","DOIUrl":null,"url":null,"abstract":"<p><p>The nuclear receptor subfamily 4 group A member 1 (<i>NR4A1</i>) gene plays a crucial role in both osteoporosis and adipogenesis. The present study investigated the mechanisms by which NR4A1 influences osteoblastogenesis and adipogenesis in human bone marrow‑derived mesenchymal stem cells (BMD‑MSCs). <i>NR4A1</i> was overexpressed or knocked down in mouse MC3T3‑E1 osteoblast cells and 3T3‑L1 adipocyte cells, as well as in PCS‑500‑012, a BMD‑MSC line. The alkaline phosphatase (ALP) assay and Alizarin Red S staining were performed using MC3T3‑E1 and BMD‑MSCs to assess ALP activity and mineralization, while Oil Red O staining was used to assess the lipid content in 3T3‑L1 cells and BMD‑MSCs. Total RNA was isolated from control, <i>NR4A1</i>‑overexpressing and <i>NR4A1</i> small interfering RNA (siRNA; <i>siNR4A1</i>)‑treated BMD‑MSCs. RNA sequencing (RNA‑seq) was performed to identify differentially expressed genes, followed by ingenuity pathway analysis (IPA) to determine the role of <i>NR4A1</i> in osteoblastogenesis and adipogenesis. <i>NR4A1</i> or <i>Nr4a1</i> knockdown tended to increase ALP activity and significantly increased calcification in BMD‑MSCs (P<0.005) and MC3T3‑E1 cells (P<0.005), respectively. By contrast, <i>NR4A1</i> or <i>Nr4a1</i> overexpression significantly decreased ALP activity and calcification. <i>NR4A1</i> or <i>Nr4a1</i> knockdown and overexpression significantly decreased and increased adipogenesis, respectively, in BMD‑MSCs (P<0.005 and <0.05, respectively) and 3T3‑L1 cells (P<0.005 in both). Treatments of BMD‑MSCs with an NR4A1 antagonist, 1,1‑bis(3'‑indolyl)‑1‑(p‑hydroxyphenyl) methane and <i>siNR4A1</i> showed similar results. RNA‑seq and IPA in control, <i>NR4A1</i> knockdown and <i>NR4A1</i> overexpressing cells indicated that Notch signaling mediated the effects of <i>NR4A1</i> in osteoblastogenesis and adipogenesis. Expression of mastermind‑like transcriptional coactivator 3 was reduced in the Notch signaling pathway in cells treated with <i>siNR4A1</i>. In conclusion, <i>NR4A1</i> suppressed osteoblastogenesis and promotes adipogenesis in human BMD‑MSCs. The present study also suggested that <i>NR4A1</i> plays a role in the progression of osteoporosis and adipogenesis by modulating the Notch signaling cascade.</p>","PeriodicalId":18818,"journal":{"name":"Molecular medicine reports","volume":"31 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544528/pdf/","citationCount":"0","resultStr":"{\"title\":\"Orphan nuclear receptor NR4A1 regulates both osteoblastogenesis and adipogenesis in human mesenchymal stem cells.\",\"authors\":\"Yilan Jin, Youngho Son, Insun Song, Yoon-Sok Chung, Yong Jun Choi\",\"doi\":\"10.3892/mmr.2024.13368\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The nuclear receptor subfamily 4 group A member 1 (<i>NR4A1</i>) gene plays a crucial role in both osteoporosis and adipogenesis. The present study investigated the mechanisms by which NR4A1 influences osteoblastogenesis and adipogenesis in human bone marrow‑derived mesenchymal stem cells (BMD‑MSCs). <i>NR4A1</i> was overexpressed or knocked down in mouse MC3T3‑E1 osteoblast cells and 3T3‑L1 adipocyte cells, as well as in PCS‑500‑012, a BMD‑MSC line. The alkaline phosphatase (ALP) assay and Alizarin Red S staining were performed using MC3T3‑E1 and BMD‑MSCs to assess ALP activity and mineralization, while Oil Red O staining was used to assess the lipid content in 3T3‑L1 cells and BMD‑MSCs. Total RNA was isolated from control, <i>NR4A1</i>‑overexpressing and <i>NR4A1</i> small interfering RNA (siRNA; <i>siNR4A1</i>)‑treated BMD‑MSCs. RNA sequencing (RNA‑seq) was performed to identify differentially expressed genes, followed by ingenuity pathway analysis (IPA) to determine the role of <i>NR4A1</i> in osteoblastogenesis and adipogenesis. <i>NR4A1</i> or <i>Nr4a1</i> knockdown tended to increase ALP activity and significantly increased calcification in BMD‑MSCs (P<0.005) and MC3T3‑E1 cells (P<0.005), respectively. By contrast, <i>NR4A1</i> or <i>Nr4a1</i> overexpression significantly decreased ALP activity and calcification. <i>NR4A1</i> or <i>Nr4a1</i> knockdown and overexpression significantly decreased and increased adipogenesis, respectively, in BMD‑MSCs (P<0.005 and <0.05, respectively) and 3T3‑L1 cells (P<0.005 in both). Treatments of BMD‑MSCs with an NR4A1 antagonist, 1,1‑bis(3'‑indolyl)‑1‑(p‑hydroxyphenyl) methane and <i>siNR4A1</i> showed similar results. RNA‑seq and IPA in control, <i>NR4A1</i> knockdown and <i>NR4A1</i> overexpressing cells indicated that Notch signaling mediated the effects of <i>NR4A1</i> in osteoblastogenesis and adipogenesis. Expression of mastermind‑like transcriptional coactivator 3 was reduced in the Notch signaling pathway in cells treated with <i>siNR4A1</i>. In conclusion, <i>NR4A1</i> suppressed osteoblastogenesis and promotes adipogenesis in human BMD‑MSCs. The present study also suggested that <i>NR4A1</i> plays a role in the progression of osteoporosis and adipogenesis by modulating the Notch signaling cascade.</p>\",\"PeriodicalId\":18818,\"journal\":{\"name\":\"Molecular medicine reports\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544528/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular medicine reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3892/mmr.2024.13368\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular medicine reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/mmr.2024.13368","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
核受体 4 亚家族 A 组 1(NR4A1)基因在骨质疏松症和脂肪生成中都起着至关重要的作用。本研究探讨了NR4A1影响人骨髓间充质干细胞(BMD-MSCs)成骨和成脂的机制。研究人员在小鼠 MC3T3-E1 成骨细胞、3T3-L1 脂肪细胞以及 BMD 间充质干细胞 PCS-500-012 株系中过表达或敲除了 NR4A1。利用碱性磷酸酶(ALP)测定和茜素红 S 染色法对 MC3T3-E1 和 BMD-MSCs 进行了检测,以评估 ALP 活性和矿化度;而油红 O 染色法则用于评估 3T3-L1 细胞和 BMD-MSCs 中的脂质含量。从对照组、NR4A1缺失组和NR4A1小干扰RNA(siRNA;siNR4A1)处理的BMD-间充质干细胞中分离总RNA。进行了 RNA 测序(RNA-seq)以确定差异表达基因,然后进行了巧妙通路分析(IPA)以确定 NR4A1 在成骨细胞生成和脂肪生成中的作用。NR4A1或Nr4a1敲除会增加ALP活性,并显著增加BMD-间充质干细胞的钙化(PNR4A1或Nr4a1过表达会显著降低ALP活性和钙化)。NR4A1或Nr4a1的敲除和过表达分别明显降低和增加了BMD-间充质干细胞的脂肪生成(PsiNR4A1显示了类似的结果)。对照组、NR4A1敲除和NR4A1过表达细胞的RNA-seq和IPA表明,Notch信号介导了NR4A1在成骨细胞生成和脂肪生成中的作用。siNR4A1 处理的细胞中,Notch 信号通路中的类主控转录辅激活子 3 的表达减少。总之,NR4A1抑制了人BMD-间充质干细胞的成骨细胞生成,促进了其脂肪生成。本研究还表明,NR4A1 通过调节 Notch 信号级联在骨质疏松症和脂肪生成过程中发挥作用。
Orphan nuclear receptor NR4A1 regulates both osteoblastogenesis and adipogenesis in human mesenchymal stem cells.
The nuclear receptor subfamily 4 group A member 1 (NR4A1) gene plays a crucial role in both osteoporosis and adipogenesis. The present study investigated the mechanisms by which NR4A1 influences osteoblastogenesis and adipogenesis in human bone marrow‑derived mesenchymal stem cells (BMD‑MSCs). NR4A1 was overexpressed or knocked down in mouse MC3T3‑E1 osteoblast cells and 3T3‑L1 adipocyte cells, as well as in PCS‑500‑012, a BMD‑MSC line. The alkaline phosphatase (ALP) assay and Alizarin Red S staining were performed using MC3T3‑E1 and BMD‑MSCs to assess ALP activity and mineralization, while Oil Red O staining was used to assess the lipid content in 3T3‑L1 cells and BMD‑MSCs. Total RNA was isolated from control, NR4A1‑overexpressing and NR4A1 small interfering RNA (siRNA; siNR4A1)‑treated BMD‑MSCs. RNA sequencing (RNA‑seq) was performed to identify differentially expressed genes, followed by ingenuity pathway analysis (IPA) to determine the role of NR4A1 in osteoblastogenesis and adipogenesis. NR4A1 or Nr4a1 knockdown tended to increase ALP activity and significantly increased calcification in BMD‑MSCs (P<0.005) and MC3T3‑E1 cells (P<0.005), respectively. By contrast, NR4A1 or Nr4a1 overexpression significantly decreased ALP activity and calcification. NR4A1 or Nr4a1 knockdown and overexpression significantly decreased and increased adipogenesis, respectively, in BMD‑MSCs (P<0.005 and <0.05, respectively) and 3T3‑L1 cells (P<0.005 in both). Treatments of BMD‑MSCs with an NR4A1 antagonist, 1,1‑bis(3'‑indolyl)‑1‑(p‑hydroxyphenyl) methane and siNR4A1 showed similar results. RNA‑seq and IPA in control, NR4A1 knockdown and NR4A1 overexpressing cells indicated that Notch signaling mediated the effects of NR4A1 in osteoblastogenesis and adipogenesis. Expression of mastermind‑like transcriptional coactivator 3 was reduced in the Notch signaling pathway in cells treated with siNR4A1. In conclusion, NR4A1 suppressed osteoblastogenesis and promotes adipogenesis in human BMD‑MSCs. The present study also suggested that NR4A1 plays a role in the progression of osteoporosis and adipogenesis by modulating the Notch signaling cascade.
期刊介绍:
Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.